ARDC Research Link Australia Research Link Australia   BETA Research
Link
Australia
  • ARDC Newsletter Subscribe
  • Contact Us
  • Home
  • About
  • Feedback
  • Explore Collaborations
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation

Need help searching? View our Search Guide.

Advanced Search

Current Selection
Australian State/Territory : NSW
Research Topic : Pre-eclampsia
Clear All
Filter by Field of Research
Applied immunology (incl. antibody engineering xenotransplantation and t-cell therapies) (1)
Biogeography and Phylogeography (1)
Genetics (1)
Invasive Species Ecology (1)
Obstetrics and Gynaecology (1)
Oncology And Carcinogenesis (1)
Oral medicine and pathology (1)
Population, Ecological and Evolutionary Genetics (1)
Filter by Socio-Economic Objective
Control of Animal Pests, Diseases and Exotic Species in Farmland, Arable Cropland and Permanent Cropland Environments (1)
Control of Animal Pests, Diseases and Exotic Species in Forest and Woodlands Environments (1)
Pre-Border Biosecurity (1)
Filter by Funding Provider
National Health and Medical Research Council (4)
Australian Research Council (1)
Filter by Status
Closed (5)
Filter by Scheme
NHMRC Project Grants (2)
Discovery Projects (1)
NHMRC Development Grants (1)
Project Grants (1)
Filter by Country
Australia (5)
Filter by Australian State/Territory
NSW (5)
VIC (1)
  • Researchers (1)
  • Funded Activities (5)
  • Organisations (1)
  • Funded Activity

    The Intrarenal Renin Angiotensin System (RAS) In Indigenous Women: An Early Indicator Of Renal Dysfunction In Women At Risk Of Pregnancy Complications

    Funder
    National Health and Medical Research Council
    Funding Amount
    $645,358.00
    Summary
    Indigenous women are twice as likely to have low birth weight babies compared to non-Indigenous women and 2.5 times as likely to develop preeclampsia, possibly because they have a much greater incidence of chronic kidney disease, predisposing them to these pregnancy outcomes. We have found a new, sensitive marker of early stage renal dysfunction in pregnancy that could be useful for detecting early stage renal disease and which is indicative of an increased risk of adverse pregnancy outcome.
    More information
    Funded Activity

    Antagonist Of Corticotrophin Releasing Hormone As Therapeutic Agents For The Prevention Of Premature Birth In Humans

    Funder
    National Health and Medical Research Council
    Funding Amount
    $376,650.00
    Summary
    In developed countries the most common cause of the death of a newborn baby is premature delivery. Pre-term delivery remains the greatest cause of neonatal mortality in the western world and a major consumer of health dollars (approx. $5-7B per year in the US alone). However, a delay in the onset of labour from 20 to 25 weeks has been shown to result in a 55% greater probability of infant survival (550 fewer deaths per 1000). This project will allow: The development of new drugs that will allow .... In developed countries the most common cause of the death of a newborn baby is premature delivery. Pre-term delivery remains the greatest cause of neonatal mortality in the western world and a major consumer of health dollars (approx. $5-7B per year in the US alone). However, a delay in the onset of labour from 20 to 25 weeks has been shown to result in a 55% greater probability of infant survival (550 fewer deaths per 1000). This project will allow: The development of new drugs that will allow the extension of pregnancy term The development of protocols that will in turn reduce neonatal mortality. Additionally we believe that these new agents will be useful in preventing the onset of labour after fetal surgery. Currently there are no effective treatments capable of substantially changing delivery dates. Available therapeutics delay the onset of labour, at best, 24 hours. However, recent exciting results from our laboratories show that rising concentrations of the placental peptide Corticotrophin Releasing Hormone (CRH) are associated with the onset of labour. Further, we have also delayed the onset of labour in pregnant sheep by infusing a relatively insoluble CRH antagonist into the sheep fetus. Labour commenced ONLY AFTER the drug was withdrawn from the mother. This project builds upon an interdisciplinary team: medicinal chemists, molecular modellers, pharmacologists and endocrinologists, to further develop an exciting Australian discovery. Successful completeion of this research will, for the first time, allow the control of pregnancy duration MAXIMISING the benefits to mother and child, reducing mortality and later life morbidities typically associated with premature birth.
    Read more Read less
    More information
    Funded Activity

    Improved Formulations Of Anti-cancer Agents 5-Fluorouracil And Oxaliplatin Using Excipient Technology

    Funder
    National Health and Medical Research Council
    Funding Amount
    $202,973.00
    Summary
    Chemotherapy plays a key role in cancer treatment, however, problems persist with severe adverse toxic effects. Combinations of anti-cancer agents give better results, but these agents still have major negative effects, for example, on veins and peripheral nerves and they must be given separately. We have developed a novel, all-in-one formulation of Oxaliplatin with 5-Fluorouracil and Leucovorin, with the potential for fewer toxic effects and improved patient care.
    More information
    Funded Activity

    HIV Assembly, Transport, Egress And Transfer From Infected Dendritic Cells

    Funder
    National Health and Medical Research Council
    Funding Amount
    $511,629.00
    Summary
    HIV-AIDS is the fourth leading killing disease worldwide, with the disease burden shifting towards women. Study of the HIV life cycle in cells known to be targetted during HIV transmission is key towards designing additional preventative measures in the form of topical gels known as microbicides. Mapping of the basic pathways of viral transport within such cells, will aid further drug discovery and-or appropriateness of use of existing drugs in microbicide formulations.
    More information
    Funded Activity

    Discovery Projects - Grant ID: DP190101500

    Funder
    Australian Research Council
    Funding Amount
    $321,000.00
    Summary
    Rapid evolution via genetic novelty in an invasive social insect. This project aims to determine how introduced Asian honey bee populations in Australia and the Pacific managed to overcome severe genetic bottlenecks to become invasive pests. The project will use advanced molecular techniques to understand rapid evolution at a focal gene that determines fitness in these populations, and to see evolution in action across the genome using a twelve-year timeline of samples. The outcome will be an en .... Rapid evolution via genetic novelty in an invasive social insect. This project aims to determine how introduced Asian honey bee populations in Australia and the Pacific managed to overcome severe genetic bottlenecks to become invasive pests. The project will use advanced molecular techniques to understand rapid evolution at a focal gene that determines fitness in these populations, and to see evolution in action across the genome using a twelve-year timeline of samples. The outcome will be an enhanced capacity to manage new outbreaks of invasive social insects of all kinds via a better understanding of how invasions establish and spread. This should provide significant benefits in the form of protecting Australian agriculture and pollination services from social insect pests.
    Read more Read less
    More information

    Showing 1-5 of 5 Funded Activites

    Advanced Search

    Advanced search on the Researcher index.

    Advanced search on the Funded Activity index.

    Advanced search on the Organisation index.

    National Collaborative Research Infrastructure Strategy

    The Australian Research Data Commons is enabled by NCRIS.

    ARDC CONNECT NEWSLETTER

    Subscribe to the ARDC Connect Newsletter to keep up-to-date with the latest digital research news, events, resources, career opportunities and more.

    Subscribe

    Quick Links

    • Home
    • About Research Link Australia
    • Product Roadmap
    • Documentation
    • Disclaimer
    • Contact ARDC

    We acknowledge and celebrate the First Australians on whose traditional lands we live and work, and we pay our respects to Elders past, present and emerging.

    Copyright © ARDC. ACN 633 798 857 Terms and Conditions Privacy Policy Accessibility Statement
    Top
    Quick Feedback